MDMA loses bid for use in PTSD therapy.

It looks like not all hope is lost.
It does appear that Lycos Pharmaceuticals testing failed to meet the requirements for approval due to the way the testing was done and not the drug itself. It could be several years before they will come back to the FDA for approval and that's very unfortunate to those who are suffering.
There are other manufactures and universities who are continuing with clinical testing now that may come before the FDA for approval sooner.
Let's hope.